Bridgeway Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-971,800
| Closed | -$2.1M | – | 1452 |
|
|
2019
Q3 | $2.1M | Hold |
971,800
| – | – | 0.03% | 490 |
|
|
2019
Q2 | $3.05M | Hold |
971,800
| – | – | 0.04% | 368 |
|
|
2019
Q1 | $3.62M | Hold |
971,800
| – | – | 0.05% | 321 |
|
|
2018
Q4 | $2.82M | Hold |
971,800
| – | – | 0.04% | 368 |
|
|
2018
Q3 | $2.56M | Sell |
971,800
-100,000
| -9% | -$263K | 0.02% | 550 |
|
|
2018
Q2 | $2.51M | Buy |
1,071,800
+220,800
| +26% | +$517K | 0.03% | 545 |
|
|
2018
Q1 | $2.5M | Hold |
851,000
| – | – | 0.03% | 509 |
|
|
2017
Q4 | $2.33M | Buy |
851,000
+801,000
| +1,602% | +$2.19M | 0.03% | 543 |
|
|
2017
Q3 | $170K | Hold |
50,000
| – | – | ﹤0.01% | 1303 |
|
|
2017
Q2 | $124K | Hold |
50,000
| – | – | ﹤0.01% | 1345 |
|
|
2017
Q1 | $114K | Hold |
50,000
| – | – | ﹤0.01% | 1327 |
|
|
2016
Q4 | $106K | Sell |
50,000
-428,400
| -90% | -$908K | ﹤0.01% | 1357 |
|
|
2016
Q3 | $1.6M | Hold |
478,400
| – | – | 0.02% | 614 |
|
|
2016
Q2 | $1.5M | Hold |
478,400
| – | – | 0.02% | 633 |
|
|
2016
Q1 | $1.59M | Hold |
478,400
| – | – | 0.03% | 591 |
|
|
2015
Q4 | $1.69M | Buy |
478,400
+90,300
| +23% | +$320K | 0.03% | 540 |
|
|
2015
Q3 | $1.95M | Sell |
388,100
-6,300
| -2% | -$31.7K | 0.04% | 495 |
|
|
2015
Q2 | $2.54M | Sell |
394,400
-2,800
| -0.7% | -$18K | 0.05% | 429 |
|
|
2015
Q1 | $2.79M | Buy |
397,200
+54,700
| +16% | +$385K | 0.06% | 400 |
|
|
2014
Q4 | $2.64M | Buy |
342,500
+27,320
| +9% | +$211K | 0.06% | 415 |
|
|
2014
Q3 | $2.35M | Buy |
315,180
+7,480
| +2% | +$55.9K | 0.06% | 422 |
|
|
2014
Q2 | $2.98M | Sell |
307,700
-6,700
| -2% | -$64.9K | 0.08% | 366 |
|
|
2014
Q1 | $2.61M | Sell |
314,400
-5,900
| -2% | -$49K | 0.07% | 395 |
|
|
2013
Q4 | $2.7M | Buy |
320,300
+22,200
| +7% | +$187K | 0.08% | 349 |
|
|
2013
Q3 | $2.38M | Buy |
298,100
+39,650
| +15% | +$316K | 0.08% | 343 |
|
|
2013
Q2 | $2M | Buy |
+258,450
| New | +$2M | 0.08% | 333 |
|